Existing data suggest that immune reactions reduce the lifespan of animal-derived heart valves implanted in cardiac patients. An EU-funded project discovered how to overcome this limitation, to produce valves with improved biocompatibility and novel immunological strategies that will benefit younger patients in particular.Powered by WPeMatico